1. Home
  2. ZLAB vs RAMP Comparison

ZLAB vs RAMP Comparison

Compare ZLAB & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • RAMP
  • Stock Information
  • Founded
  • ZLAB 2013
  • RAMP 2018
  • Country
  • ZLAB China
  • RAMP United States
  • Employees
  • ZLAB N/A
  • RAMP N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • RAMP EDP Services
  • Sector
  • ZLAB Health Care
  • RAMP Technology
  • Exchange
  • ZLAB Nasdaq
  • RAMP Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • RAMP 1.8B
  • IPO Year
  • ZLAB 2017
  • RAMP 1987
  • Fundamental
  • Price
  • ZLAB $36.40
  • RAMP $33.55
  • Analyst Decision
  • ZLAB Buy
  • RAMP Buy
  • Analyst Count
  • ZLAB 5
  • RAMP 7
  • Target Price
  • ZLAB $54.28
  • RAMP $38.57
  • AVG Volume (30 Days)
  • ZLAB 886.5K
  • RAMP 502.3K
  • Earning Date
  • ZLAB 08-05-2025
  • RAMP 08-06-2025
  • Dividend Yield
  • ZLAB N/A
  • RAMP N/A
  • EPS Growth
  • ZLAB N/A
  • RAMP N/A
  • EPS
  • ZLAB N/A
  • RAMP N/A
  • Revenue
  • ZLAB $418,326,000.00
  • RAMP $745,580,000.00
  • Revenue This Year
  • ZLAB $44.07
  • RAMP $10.01
  • Revenue Next Year
  • ZLAB $49.13
  • RAMP $9.39
  • P/E Ratio
  • ZLAB N/A
  • RAMP N/A
  • Revenue Growth
  • ZLAB 43.72
  • RAMP 13.03
  • 52 Week Low
  • ZLAB $16.01
  • RAMP $21.45
  • 52 Week High
  • ZLAB $44.34
  • RAMP $36.08
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 52.67
  • RAMP 61.81
  • Support Level
  • ZLAB $34.79
  • RAMP $32.68
  • Resistance Level
  • ZLAB $36.73
  • RAMP $33.57
  • Average True Range (ATR)
  • ZLAB 1.23
  • RAMP 0.90
  • MACD
  • ZLAB -0.46
  • RAMP 0.02
  • Stochastic Oscillator
  • ZLAB 25.91
  • RAMP 92.59

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.

Share on Social Networks: